Skip to content
2000
Volume 20, Issue 7
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Epilepsy responds to pharmacotherapy in its initial stages. The response of some forms of epilepsy, like the refractory epilepsy, is extremely low. Surgical management of epilepsy is associated with complications, which necessitates the search for novel and modern strategies for the treatment of epilepsy. Neuroprotection and neuronal regeneration are the major targets that must be accomplished by the new strategies. Hematopoietic Stem Cell (HSCs) therapy for epilepsy has shown promising results in pre-clinical studies with marginal clinical effects. This review explores the characteristics, mechanism of action, and clinical significance of HSCs therapy for the treatment of epilepsy.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527320666210218085816
2021-08-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527320666210218085816
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test